|
|
|
| Clinical Efficacy of Osimertinib Combined with Reduced-dose Pemetrexed in Elderly Patients with Advanced NSCLC with EGFR Mutation |
| HU Sheng, WANG Cong, SUN Zhixiao. |
| First-author's address: Department of Respiratory and Critical Care Medicine, Yancheng First People's Hospital, Yancheng 224008, China |
|
|
|
|
|
|
Received: 29 October 2025
|
|
|
|
|
|
|
